Quick Answer
BioAge Labs, Inc. reported Total Assets of $294.89 million for fiscal year 2025.
BioAge Labs, Inc. Total Assets — Annual History
| Fiscal Year | Total Assets | YoY Change |
|---|---|---|
| 2025 | $294.89M | -17.7% |
| 2024 | $358.23M | +1281.9% |
| 2023 | $25.92M | — |
Quarterly Total Assets
| Quarter Ending | Total Assets | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $305.09M | -9.6% | -5.3% |
| June 30, 2025 | $322.15M | — | -6.3% |
| March 31, 2025 | $343.84M | — | -4.0% |
| December 31, 2024 | $358.23M | +1281.9% | +6.2% |
| September 30, 2024 | $337.38M | — | +1201.4% |
| December 31, 2023 | $25.92M | — | — |
- BioAge Labs, Inc. showed a decrease of -17.7% in Total Assets compared to the prior fiscal year.
- Over the 2023–2025 period, BioAge Labs, Inc.’s total assets has grown by 1037.5% (from $25.92 million to $294.89 million).
- The most recent figure is from BioAge Labs, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 24, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: